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Mechanically and thermally robust microcapsules 
containing diglycidyl ether bisphenol A-based epoxy resin 
and a high-boiling-point organic solvent were synthesized 
in high yield using in situ polymerization of urea and 
formaldehyde in an oil-in-water emulsion. Microcapsules 
were characterized in terms of their size and size 
distribution, shell surface morphology and thermal 
resistance to the curing cycles of commercially used epoxy 
polymers. The size distribution of the capsules and 
characteristics such as shell thickness can be controlled by 
the specific parameters of microencapsulation, including 
concentrations of reagents, stirrer speed and sonication. 
Selected microcapsules, and separated core and shell 
materials, were analysed using thermogravimetric analysis 
and differential scanning calorimetry. It is demonstrated 
that capsules lose minimal 2.5 wt% at temperatures no 
higher than 120
◦
 C. These microcapsules can be applied to 
self-healing carbon fibre composite structural materials, 









Microencapsulation of reactive ingredients has attracted 
interest in a variety of fields, including medicine, 
agrochemicals, food additives and cosmetics [1–3]. More 
recently, microencapsulation has been explored in the 






structural materials [4–6]. The active ingredients, including monomers, catalysts and hardeners, are 
embedded in a host material, ready for release and polymerization, the healing process being typically 
triggered by a propagating crack that ruptures the microcapsules, releasing the encapsulated materials. 
Chemical reaction (typically polymerization) or physico-chemical processes lead to bonding of the crack 
surfaces and restoration of the material’s integrity [4–6]. An early example of a capsular self-healing 
system used dicyclopentadiene (DCPD) as the encapsulated monomer and dispersed particles of Grubbs’ 
catalyst to trigger hardening [7]. In this approach, the released DCPD comes into contact with the catalyst 
and undergoes ring-opening metathesis polymerization; the poly(urea–formaldehyde) (UF) microcapsules 
containing the DCPD were prepared using in situ polymerization in an oil-in-water emulsion [8]. Using 
related methodology, chemistries including DCPD/ethylidene-norbornene [9], organic solvents [10,11], 
epoxy resins [12] and their cross-linkers such as amines [13,14], thiols [15] and glycidyl methacrylate 
[16] have been successfully encapsulated. Typical capsule shell materials include UF, melamine–UF 
(UMF) and melamine–formaldehyde (MF), which have proved promising for sequestration of various 
reactive ingredients [4,5,17,18]. 
 
The usual method for microencapsulation using these materials is that liquid core reagents are first 
dispersed in an aqueous phase containing surfactants/stabilizers and shell-forming monomers. Initially, 
the shell-forming reagents form a low-molecular-weight pre-polymer, which grows with time and 
deposits on the interface between the water and oil phases. Polycondensation of urea and formaldehyde 
continues at the interface and leads to a solid and non-permeable capsule shell. Most of the capsule 
characteristics (e.g. diameter, wall thickness) can be influenced by controlling the parameters of the 
emulsification procedure: reaction time, temperature, core-to-shell reagent ratio and stirring speed 
[19,20].  
Here, we report an extensive study on microencapsulation of diglycidyl ether of bisphenol A epoxy 
resin and organic solvent (ethyl phenylacetate) using in situ polymerization in an oil-in-water emulsion. 
The primary aim of this research was to develop methods by which the exact attributes of microcapsules 
can be defined, which is necessary in the application of such microcapsules in self-healing structural 
components. As proof of concept of this application, a flat laminate with embedded microcapsules and 
dispersed Lewis acid (LA) catalyst (Sc(OTf)3) was manufactured, with the embedded microcapsules and 
catalyst in the interleave region. 
 




Ethyl phenylacetate (EPA, C6H5CH2COOC2H5), urea (NH2CONH2), poly(ethylene-alt-maleic) 
anhydride (EMA, Mw = 100 000–500 000, powder), resorcinol (C6H4-1,3-(OH)2), formaldehyde (37 
wt% in H2O, CH2O) and ammonium chloride (NH4Cl) were purchased from Sigma-Aldrich and used as 
received. Sodium hydroxide (NaOH) was purchased from Fisher Scientific. Commercial epoxy resin 
(EPON 828) was purchased from Polysciences Inc. and also used as received. Encapsulation was 
performed in a round-bottomed glass vessel made in-house, with the following parameters: internal width 
75 mm, height 135 mm and curvature depth 15 mm; the vessel was also fitted with a PTFE lid. An 
overhead stirrer (Caframo Petite Digital Model BDC 250) equipped with a two-bladed axial propeller (35 
mm wide) was used for emulsification and mixing. 
 
 
(b) In situ encapsulation of organic solvent and epoxy resin 
 
Poly(UF) microcapsules containing EPON 828–ethyl phenylacetate (table 1) were synthesized via in situ 
polymerization as described in the literature [12]. In a typical procedure, 125 ml of a 1.2 wt% aqueous 
solution of poly(ethylene-alt-maleic) anhydride was placed in the previously defined vessel and 2.50 g 
urea, 0.250 g resorcinol and 0.250 g ammonium chloride were added and stirred at room temperature 











Table 1. Systematic names and designations of microcapsule core materials used in the study. The wt% is measured by 
weight per cent relative to the organic encapsulated phase assuming that density is equal to 1 g ml−1. 
 
systematic name EPON 828 (wt%) EPA (wt%) 
E2.5 2.5 97.5 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
E50 50 50 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
E75 75 25 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
E90 90 10 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
was adjusted by dropwise addition of NaOH (≈0.2 N) from 2.6 to 3.2 and allowed to equilibrate. Stirring 
speed was increased to the desired rate and 60 ml of a 2.5 wt% solution of epoxy resin (EPON 828) in 
EPA was dispersed under continued stirring. This emulsion was left at the desired stirring rate (from 800 
to 1500 r.p.m.) for a further 10 min and then 6.33 g of aqueous formaldehyde solution was added. In 
experiments requiring sonication, the tapered 1/8” tip sonication horn of a 750 W ultrasonic homogenizer 
was immersed in the emulsion, which was sonicated for 3–6 min. The temperature of the system was 
increased to 55
◦
 C. After 4 h, the stirrer was stopped and the microcapsule slurry was left to settle at room 
temperature for 24 h. Next, capsules were isolated by filtration and rinsed a few times with water and 
then ethanol. The isolated capsules were dried at 55
◦
 C for 24 h. The yield of microcapsules was 
calculated relative to the mass of used materials.  
(c) Size and size distribution analysis 
 
Size and size distribution of microcapsules were analysed by a Zeiss Optical Microscope AXIO 
Imager.M2 equipped with a video camera AxioCam ICc 1. At least 500 measurements of capsule 
diameters were taken; for the size distribution, image analysis software (ImageJ) was used. 
 
(d) Surface morphology 
 
Surface morphology analysis was performed with a scanning electron microscope JEOL SEM 5600LV. 
Dry capsules were placed on the conductive tab and sputter-coated before analysis with a layer of Ag/Pd. 
Scanning electron microscopy (SEM) was also used to investigate fracture surfaces of delaminated 
double cantilever beam (DCB) test specimens. 
 
(e) Thermal analysis of microcapsules, and their core and shell materials 
 
Thermal analysis was performed using thermogravimetric analysis (TGA) and differential scanning 
calorimetry (DSC). Mass loss of capsules was recorded under non-isothermal conditions from 25
◦
 C to 
500
◦
 C and during isothermal measurements at different temperatures by a TA Instruments Q500 TGA. 
Isothermal experiments were performed at 80, 100, 120 and 140
◦
 C for 2 h. Dynamic analysis of the 





(f) Composite manufacturing with embedded microcapsules 
 
Flat composite laminates with embedded microcapsules and solid-phase LA were manufactured using 
carbon/epoxy resin tape (SE 70, Gurit, UK) and adhesive resin film (SA 70, Gurit, UK) using a standard 
hand lay-up technique. Laminates after lay-up (16 plies (160 × 195 mm)) were placed on an aluminium 
tool plate, sealed with a vacuum bag and consolidated according to the manufacturer’s recommendations 
at 100
◦
 C for 100 min. Microcapsules and Sc(OTf)3 particles were mixed with a resin paste (SA 70, 
Gurit, UK) at 26 and 2.5 wt%, respectively, and screen-printed onto the middle plane surface during the 
lay-up. An additional control specimen containing the resin-filled interleave region was manufactured. 








were removed from the vacuum bag, grit-blasted on their front and trimmed on the edges using a 
diamond saw. Composite plates were then cut into DCB specimens (20 mm × 175 mm) and piano hinges 
were bonded to the specimens at the pre-cracked end using Araldite 2014 structural adhesive and left at 
room temperature until fully cured. 
 
(g) Tests for self-healing 
 
Tests for mode I interlaminar fracture were performed for virgin and healed DCB specimens. A standard 
test machine (Shimadzu AGX-X) equipped with 1 kN load cell and a video camera was used. Tests were 
performed in accordance with the ASTM 5528-13 standard method [21]. Specimens were tested in crack 
opening mode at 3 mm min
−1
 displacement rate, from the release film to the end of the interleave resin 
region containing microcapsules. After testing, specimens were unloaded, sealed and left at 80
◦
 C for 24 
h. The healing efficiency (η) was calculated from the ratio of the healed maximum peak load (PHealed) 
to the virgin maximum peak load (PVirgin): 




3. Results and discussion 
 
(a) Encapsulation of commercial epoxy resins and solvents 
 
UF microcapsules containing epoxy resin–solvent mixtures were synthesized in variable size by in situ 
polymerization in an oil-in-water emulsion (tables 2 and 3). Capsules containing from 2.5 to 90 wt% of 
the commercial epoxy resin (EPON 828) in ethyl phenylacetate were synthesized by a method adopted 
from the literature and by a modification of this method (table 4). 
 
(b) Influence of stirring speed/sonication on microcapsule size 
 
Using a literature method [12], the dependence of microcapsule size on epoxy resin concentration in the 
organic phase was investigated. For all specimens, 60 ml of epoxy resin/solvent containing 2.5, 50, 75 or 
90 wt% of epoxy resin was dispersed in 125 ml of water at 800 r.p.m. Organic phases containing 2.5 and 
50 wt% of epoxy resin were easily dispersed at this rate and capsules resulted in a wide range of sizes 
(table 2). At 75 and 90 wt% EPON 828, the high viscosity of these formulations resulted in very poor 
dispersion at 800 r.p.m.; increasing the stirring rate (to 1000 r.p.m.) was necessary for successful 
encapsulation.  
The dependence of size and size distribution of the microcapsules on stirring rate, sonication and 
surfactant/stabilizer concentration is reported in table 3. As expected, the size of microcapsules is 
decreased with increasing stirring speed (figure 1a); a representative size distribution at 1100 r.p.m. is 
given in figure 1b. Unfortunately, at higher stirring rates (1200– 1500 r.p.m.) the microcapsules rupture 
(see entries 9 and 10 in table 3) [16], putting a lower limit of around 100 µm on the size of microcapsules 
that can be accessed by this method. This is potentially a problem in terms of application to self-healing 
composites in that it is presumed that smaller diameters will in general have a less detrimental influence 
on the mechanical performance of the structural material. 
 
To obtain microcapsules with diameters below 100 µm, sonication was required as an alternative 
homogenization method [22,23]. To ensure full interfacial coverage of newly created droplets, the 
surfactant/stabilizer (poly(ethylene-alt-maleic) anhydride) load was increased to 2.5 wt% relative to the 
mass of dispersed core materials. After sonication of the emulsion for 3 min at 80% amplitude, the 
droplet size was decreased sufficiently that microcapsules in the 100 µm range could be prepared at 800 
r.p.m. stirring speed, rather than at the 1000 r.p.m. required without sonication. Increasing the 
surfactant/stabilizer concentration further (table 3, entries 2–  
4) resulted in even smaller capsules (as low as 4 ± 2 µm), still in acceptable yields. Figure 2 represents a 












































































Table 2. Encapsulation conditions of EPON 828 at variable concentrations in an oil-in-water emulsion. 
 
EPON 828 in water organic surfactant agitation mean 
organic phase (wt%) phase (ml) phase (ml) amount (wt%)
a 
rate (r.p.m.) diameter (µm) 
2.5 125 60 1 800 140 ± 80 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
50 125 60 1 800 200 ± 140 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
75 125 60 1 1000 170 ± 110 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
90 125 60 1 1000 190 ± 110 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
a The wt% is measured by weight per cent relative to the organic encapsulated phase assuming that density is equal to 1 g ml−1. 
 
Table 3. Encapsulation conditions of EPON 828 in an oil-in-water emulsion. Reaction volume included 30 ml of 
organic phase at constant concentration of epoxy resin (10 wt%) to organic solvent dispersed in 62.5 ml of water 
containing shell-forming monomers (urea, resorcinol and formaldehyde). 
 
  agitation amount of time of temperature yield mean 
no. pH rate surfactant (wt%)
a 
sonication (min) (
◦ C) (%) diameter (µm) 
1 3.15 800 2.5 3 55 81.3 100 ± 40 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 3.10 800 3.75 3 55 74.5 60 ± 40 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
3 3.11 800 5 3 55 66.1 6 ± 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
4 3.09 800 10 5 55 51.0 4 ± 2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
5 3.11 800 2.5 0 55 91.6 180 ± 100 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
6 3.72 900 2.5 0 55 80.5 160 ± 80 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
7 3.09 1000 2.5 0 55 65.5 100 ± 40 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
8 3.57 1100 2.5 0 55 41.6 80 ± 80 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
9 3.8 1200 2.5 0 55 — — 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
10 3.6 1500 2.5 0 55 — — 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
a The wt% is measured by weight per cent relative to the organic encapsulated phase assuming that density is equal to 1 g ml−1. 
 
Table 4. Adopted and modified methods of epoxy resin–solvent encapsulation in an oil-in-water emulsion.  
       
encapsulation method aqueous phase (ml) EMA (wt%)
a 
urea (g) NH4Cl (g) resorcinol (g) formalin (g) 
(a) literature [12] 125 1 2.50 0.250 0.250 6.33 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(b) modified 62.5 2.5–10 1.25 0.125 0.125 3.16 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
a The wt% is measured by weight per cent relative to the organic encapsulated phase assuming that density is equal to 1 g ml−1. 
 
 
(c) Shell wall morphology 
 
Scanning electron micrographs of exemplary microcapsules prepared by adopted and modified methods 
are presented in figure 3b and 3a, respectively. Both types of microcapsules contained 75 wt% of the 
epoxy resin and 25 wt% of ethyl phenylacetate. In both cases, the shell material comprises a thin 
continuous inner shell (with diameter about 160–200 nm) and a thicker rough exterior wall. It has been 
reported that the continuous membrane is formed as urea and formaldehyde react in the aqueous phase, 
resulting in a low-molecular-weight polymer that collapses at the oil/water interface. As the UF reaction 
progresses, the rough exterior is formed as colloidal poly(UF) particles coalesce, and deposit along the 
interface [8,19]. As can be seen in figure 3, the modified method in which a higher concentration of 
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Figure 1. Mean diameter of microcapsules containing 10 wt% of EPON 828: (a) diameter of microcapsules as a function of 
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Figure 2. Size distribution of EPON 828–EPA microcapsules prepared at increased 
surfactant stabilizer concentration (5 wt%) and after sonication. 
 
 
gives a much more even shell wall morphology, presumably due to the enhanced stabilization of the 
nascent microcapsules. This enhanced stabilization reduces the amount of small agglomerates that can 
accrete on the surface of the microcapsules. 
 
(d) Load of shell-forming materials 
 
The mechanical properties of microcapsules are important in their application to self-healing materials, 
with the requirements to be sufficiently robust to survive structural material manufacture but able to burst 
after a damage event. It is therefore desirable to be able to systematically change the shell wall thickness, 
with thicker materials expected to be more robust. To this end, the amount of shell wall-forming materials 
(urea, NH4Cl, resorcinol, formaldehyde and the poly(EMA) surfactant/stabilizer) was increased relative 





















































Figure 3. Scanning electron micrographs of (a) microcapsules containing 75 wt% of epoxy resin in organic solvent 
(ethyl phenylacetate) prepared by modified method without application of sonication (tables 3 and 5) and (b) 
microcapsules prepared by method adopted from the literature (table 2, E75) [12]. 
 
monomer and aqueous phase, while keeping the ratio between these shell wall-forming materials 
constant. In total, 150 and 200% increases by weight compared to previous runs were investigated (table 
5). 
 
The corresponding SEM micrographs of the resulting samples are presented in figure 4. We observe 
that increasing the concentration of shell wall-forming materials leads to highly agglomerated 
microcapsules. This is presumably due to the fast condensation of the pre-polymer prior to deposition at 
the water–oil interface and is a clear limitation of this method. 
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Experiments to explore the thermal stability of microcapsules were performed for E50 microcapsules 












































Figure 4. Microcapsules prepared using (a,b) in situ polymerization at 50% and (c,d) 100% excess of shell-forming 
monomers (urea, resorcinol and formaldehyde). Reaction was carried out in an oil-in-water emulsion containing 75 wt% of 
epoxy resin (EPON 828) and 25 wt% of high-boiling-point organic solvent (ethyl phenylacetate) as oil phase. 
 
Table 5. Load of the shell-forming materials used in the study. The encapsulation was carried out as for 
previous samples at the same conditions of stirring (800 r.p.m.), pH (3.15) and temperature (55◦C). 
 
encapsulation method aqueous phase (ml) EMA (wt%)
a 
urea (g) NH4Cl (g) resorcinol (g) formalin (g) 
(a) standard 62.5 2.5 1.25 0.125 0.125 3.16 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(b) 150% 62.5 2.5 1.875 0.1875 0.1875 4.74 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(c) 200% 62.5 2.5 2.5 0.25 0.25 6.32 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
a Weight per cent measured relative to mass of dispersed organic phase (30 ml). 
 
 
analysed non-isothermally from 25 to 500
◦
 C. The first mass loss observed at 170
◦
 C is associated with 
thermal decomposition of the shell polymer, with similar behaviour observed for separated poly(UF) shell 
wall material. Another onset of mass loss at 210–220
◦
 C corresponds to the boiling point of encapsulated 
ethyl phenylacetate, which continues to 310
◦
 C. During continuous heating at high temperatures, the 
encapsulated epoxy resin partially polymerized, with onset at 360
◦
 C. A similar trend is observed for a 
non-encapsulated core epoxy resin–organic solvent mixture (50% EPON 828 and 50% EPA). To further 
determine the thermal stability of microcapsules, isothermal experiments were performed at 80, 100, 120 
and 140
◦
 C for 2 h. The representative mass loss is presented in figure 6b. It was observed that 
microcapsules lose 2.5 wt% of their total mass at 80, 100 and 120
◦
 C. This mass loss is associated with 
the removal of residual water from the shell wall, leading to further cross-linking of the poly(UF). After 2 
h at 140
◦
 C, an increased mass loss of 6.5% was observed as a result of microcapsule decomposition. 
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Figure 5. (a) Representative TGA for microcapsules containing 50 wt% of commercial epoxy resin and 50 wt% of 
high-boiling-point solvent (ethyl phenylacetate) and separated core and shell materials. (b) Exemplary DSC 
analysis of separated poly(UF) shell material illustrating its softening point. (Online version in colour.) 
 
 
DSC was used to determine the thermal behaviour of microcapsules and separated core/shell 
materials. The glass transition temperature for the separated shell material is 125
◦
 C and this is followed 
by an endotherm with a peak temperature at 145
◦
 C (figure 6a). This observed glass transition 
temperature is the upper usage limit of the prepared capsules; beyond this temperature, softening leads to 
a release of core material. Furthermore, at 237
◦
 C we observed an onset of ethyl phenylacetate 
evaporation combined with homopolymerization of diglycidyl ether of bisphenol A and its thermal 
decomposition. 
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Preliminary experiments for recovery of fracture properties (mode I) in a carbon fibre reinforced polymer 
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Figure 6. (a) DSC curves for microcapsules and separated core materials. (b) Representative 
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Figure 7. DCB test specimen containing microcapsules in the interleave and solid-phase catalyst in the interleave 
region. The specimen geometry is adopted from ASTM standard test method D5528-01 [21]. 
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Figure 8. Representative crack arrest for DCB test specimens containing microcapsules 
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Figure 9. Fracture surface illustrating ruptured microcapsules, particles of embedded 
LA catalyst particles and thin film of epoxy resin covering the fracture surfaces. 
 
catalyst (Sc(OTf)3) [24] were embedded in a crack propagation region of a unidirectional laminate and 
tested [21] (figure 7). The presence of a Lewis acid (or Lewis base) catalyst within the structure is crucial 
for successful polymerization of released epoxy resin. The difference in maximum peak loads recorded 
on the load–displacement curves (figure 8) for initially fractured specimens and for healed ones was used 
to quantify self-healing efficiency. A 10% crack arrest was observed for specimens healed at 80
◦
 C after 
24 h (table 6). This is somewhat lower compared to our previous reports of similar technology [22,24,25] 
and demonstrates that the test method itself and the manufacturing methods for test specimens are 
important in fully appreciating the performance of this technology. Crack arrest in this case is associated 
with cross-linking of released epoxy 
  
 
Table 6. Designations and load of interleave containing healing chemistries.   
       
designation wt%
a 
capsule size (µm) initial load PVirgin (N) healed load PHealed (N) η (%)
b healing temp. (◦ C) 
control — — 81.0 ± 6.4 — — 80 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
autonomous  26 170 ± 110 57.2 ± 10.6 5.5 ± 1.5 9.9 ± 3.5  80 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
a Weight of microcapsules calculated according to the mass of epoxy resin used to fill the interleave.  
b Healing efficiency calculated from the difference in maximum observed load on load–displacement curves for initially 
fractured and healed DCB specimens. 
 
resin triggered by separately embedded Lewis acid catalyst, indicating that microcapsules are not 
decomposed during harsh manufacturing conditions of selected epoxy matrix CFRP and that the epoxy 
resin stored in capsules is in liquid form and is ready for polymerization after release by a propagating 
crack.  
The SEM analysis performed for fracture surfaces revealed ruptured microcapsules, unused Sc(OTf)3 
catalyst particles and a thin film of polymerized epoxy resin bridging the fractured surfaces (figure 9). 





In summary, epoxy resin-filled microcapsules can be reliably synthesized via an oil-in-water 
microemulsion method. Increased concentrations of surfactant/stabilizer in general are beneficial, 
allowing for more even microcapsules to be accessed with smaller diameters and at lower stirring rates 
when used in conjunction with sonication. There are limits to shell wall thickness, since higher 
concentrations of the necessary reagents lead to unacceptable levels of agglomeration. Thermal stability 
is limited by the softening temperature of the shell wall polymer. Preliminary application of these 
materials in self-healing applications shows promising results when used together with Lewis acidic 
catalysts for the polymerization of the encapsulated epoxy monomer. 
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